<- Go Home
Beximco Pharmaceuticals Limited
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Market Cap
BDT 38.8B
Volume
421.1K
Cash and Equivalents
BDT 1.7B
EBITDA
BDT 10.5B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
BDT 20.6B
Profit Margin
44.42%
52 Week High
BDT 127.00
52 Week Low
BDT 64.20
Dividend
4.60%
Price / Book Value
0.78
Price / Earnings
6.11
Price / Tangible Book Value
0.88
Enterprise Value
BDT 46.1B
Enterprise Value / EBITDA
4.35
Operating Income
BDT 8.8B
Return on Equity
12.45%
Return on Assets
7.62
Cash and Short Term Investments
BDT 2.9B
Debt
BDT 6.2B
Equity
BDT 53.6B
Revenue
BDT 46.3B
Unlevered FCF
BDT 2.8B
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium